Waters Corporation

NYSE WAT

Waters Corporation Price to Sales Ratio (P/S) on January 14, 2025: 8.28

Waters Corporation Price to Sales Ratio (P/S) is 8.28 on January 14, 2025, a 33.92% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Waters Corporation 52-week high Price to Sales Ratio (P/S) is 8.28 on January 14, 2025, which is 0.00% below the current Price to Sales Ratio (P/S).
  • Waters Corporation 52-week low Price to Sales Ratio (P/S) is 5.83 on July 01, 2024, which is -29.59% below the current Price to Sales Ratio (P/S).
  • Waters Corporation average Price to Sales Ratio (P/S) for the last 52 weeks is 6.88.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
NYSE: WAT

Waters Corporation

CEO Dr. Udit Batra Ph.D.
IPO Date Nov. 17, 1995
Location United States
Headquarters 34 Maple Street
Employees 7,900
Sector Materials
Industries
Description

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Similar companies

ICLR

ICON Public Limited Company

USD 200.24

-8.14%

IDXX

IDEXX Laboratories, Inc.

USD 418.63

-0.94%

SHC

Sotera Health Company

USD 12.76

-2.52%

ILMN

Illumina, Inc.

USD 136.48

-5.37%

RVTY

Revvity, Inc.

USD 120.73

-1.61%

IQV

IQVIA Holdings Inc.

USD 197.96

-3.26%

CRL

Charles River Laboratories International, Inc.

USD 178.08

-6.34%

TMO

Thermo Fisher Scientific Inc.

USD 556.99

0.27%

TWST

Twist Bioscience Corporation

USD 42.75

-1.91%

DHR

Danaher Corporation

USD 237.62

-0.94%

MTD

Mettler-Toledo International Inc.

USD 1.27 K

0.33%

StockViz Staff

January 15, 2025

Any question? Send us an email